The Drug Control and Enforcement (Amendment) Act, 2017

1. This Act may be cited as the Drug Control and Enforcement (Amendment) Act, 2017 and shall be read as one with the Drug Control and Enforcement Act herein after referred to as the “principal Act.” PART II AMENDMENT OF VARIOUS PROVISIONS Amendment of section 1

2. The principal Act is amended in section 1(3): (a) by inserting the word “also” between the words “shall” and “apply” appearing in subsection (3); (b) by deleting the word “aircraft” appearing in paragraph (a) and substituting for it the words “any other conveyance”; 3 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 (c) in paragraph (b), by: deleting (i) substituting for it the following: subparagraph (i) and (ii) (iii) in “(i) a citizen or a person who ordinarily resides the United Republic”; deleting the word “ship” appearing in the first line of subparagraph (iv) and substituting the word “conveyance”; deleting the word “ship” appearing in subparagraph (v) and substituting for it the word “conveyance”. for it Amendment of section 2 (a)

3. The principal Act is amended in section 2, by: inserting in the appropriate alphabetical order the following new definitions: “Convention State” means any state which is a signatory to the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988, or any other related international conventions or protocol or other instrument amending it; “khat plant” means a flowering green leaf plant of the family celastraceae which contains the alkaloid chemical compounds named cathinone and cathine; “officer” means a person appointed or employed in accordance with section 8(1) or any other law enforcement officer under other laws of Tanzania enforcing or performing powers and duties under this Act;” (b) adding at the end of the definition of the term “cannabis plant” the words “containing tetrahydro-cannabinol”; 4 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 (c) deleting “chemical precursors” and “cannabis oil”; the definitions of the terms (d) deleting the definition of the term “Council” and substituting for it the following- ““Council” means the National Drug Control Council established under section 5”; (e) in the definition of the term “court”- (i) (ii) (iii) by deleting paragraph (a) and substituting for it the following: “(a) in of respect an for offence contravention of section 7, 11,15A,17, 18, 19, 20, 21, 22, 25, 34, 39, 42, 47, 51A, 54 or means 65 subordinate court”; (b) and by deleting paragraph renaming paragraph (c) as paragraph (b); and in (b), by inserting between the word “section” and figure “16”, figure “15”; renamed paragraph (f) by deleting the definition of the term “precursor chemical” and substituting for it the following: “precursor chemical” means a chemical used in the process of manufacturing of narcotic drugs or psychotropic substance as defined in Nations Article 12 of the Convention Against Illicit Trafficking of Narcotic Drugs and Psychotropic Substances, 1988 mentioned in Table I and Table II as set out in the Second Schedule to this Act”; United (g) in the definition of the term “trafficking”, by deleting the opening phrase and substituting for it the following: “trafficking” means the importation, exportation, buying, sale, giving, possession, storing, supplying, manufacturing, production, 5 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 conveyance, delivery or distribution, by any person of narcotic drug or psychotropic substance any substance represented or held out by that person to be a narcotic drug or psychotropic substance or making of any offer but shall not include-” Amendment of section 4

4. The principal Act is amended in section 4(2), by: (a) deleting the words “on drug related matters” appearing in paragraph (f) and substituting for them the words “drug offences and other related offences”; (b) adding immediately after paragraph (m), the following: “(n) conduct forensic investigation”; (c) adding immediately after subsection (4), the following: “(5) For purposes of controlling drug, drug abuse and trafficking in drugs, diversion of precursor chemicals and controlled pharmaceuticals, any other authority vested with powers to issue permit or licence to deal or engage in drug, chemicals, precursor chemicals or substances with drug related effects, shall consult the Authority before issuing import or export permit, licence or certificate. (6) The Authority may, by notice published rules the Gazzete, make prescribing procedures for implementation of subsection (5).” in Amendment of section 7

5. The principal Act is amended in section 7, by adding immediately after subsection (2) the following new subsections: “(3) The Commissioner General may, in the course of performing duties under this Act and in 6 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 accordance with other relevant laws, demand, access and obtain any information from public institutions including information collected or maintained by or on behalf of other public institutions and such institution shall be obliged to provide information as may be required. (4) Any institution which fails to comply with the requirements of this section commits an offence under this Act. is committed under (5) Subject to subsection (4), where an offence this Act by an institution, every person who, at the time the offence was committed, was in charge of, and was responsible to the institution for the conduct of the business of the institution, shall be deemed to have committed an offence and be liable to be proceeded against and punished accordingly. (6) Nothing in subsection (5) shall render a person liable for punishment, if the person proves that the offence was committed without his knowledge or has exercised all due diligence to prevent the commission of the offence.”

6. The principal Act is amended in section 9, by: (a) inserting immediately after the word “appoint” the words “the Chairman and such other” appearing in subsection (4); (b) adding immediately after subsection (5) the following new subsections: “(6) The Advisory Committee shall meet at least twice a year in regular sessions and whenever necessary, in special sessions. Amendment of section 9 (7) A the Authority shall be the Secretary to the Committee.”; and representative from (c) renumbering subsection (6) as subsection (8). Repeal and replacement of section 14

7. The principal Act is amended by repealing section 14 and replacing for it the following: “List of prohibited narcotic drugs,

14.-(1) The list of prohibited narcotic drugs, psychotropic substances 7 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 psychotropic substances or precursor chemicals or precursor chemicals shall be as set out in the First and Second Schedules to this Act. (2) Subject to subsection (1), the Minister may, by notice published in the Gazette, amend the list set out in the First and Second Schedules.”

8. Section 15 of the principal Act is amended: (a) in subsection (1), by: (i) deleting paragraph (a); (ii) renaming paragraphs (b) and (c) as paragraphs (a) and (b); (iii) deleting paragraph (b) as renamed and substituting for it the following: Amendment of section 15 “(b) traffics, diverts or illegally in any way with deals chemicals, precursor drug substances with related and effects the substances used process of manufacturing of drugs”; and in (b) by adding immediately after paragraph (b) the following new paragraph: “(c) directly or indirectly facilitates or causes any other person to be used as bondage for the purposes of drug trafficking, commits an offence and upon conviction shall be sentenced to life imprisonment.”; (c) in subsection (2), by inserting the phrase “or substances used in the process of manufacturing of drugs” between the words “effects” and “commits”; (d) by adding immediately after subsection (2), the following: “(3) For purposes of this section, a person commits an offence under subsection 8 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 (1) if such person traffics- drugs, (i) narcotic psychotropic substances weighing more than two hundred grams; precursor chemicals or substance with drug related effect weighing more than 100 litres in liquid form or 100 kilogram in solid form, or cannabis and or khat weighing more than fifty kilogram.” (ii) (iii) Addition of section 15A

9. The principal Act is amended by adding immediately after section 15 the following new section: “Prohibition on trafficking of narcotic drug or psychotropic substances or illegal dealing or diversion of precursor chemicals of less amount

15A.-(1) Any person who traffics in narcotic drugs, psychotropic substances or illegally deals or diverts precursor chemicals or substances with drug related effects or substances used in the process of manufacturing drugs of the quantity specified under this section, upon offence commits to be conviction imprisonment for a term of thirty years. (2) For purposes of this section, a person commits an offence under subsection (1) if such person traffics in and liable shall an (a) narcotic drugs, psychotropic substances weighing two hundred grams or below; (b) precursor chemicals or substance with drug related effect weighing 100 litres or below in liquid form, or 100 kilogram or below in solid form; (c) cannabis or khat weighing fifty than not more kilogram.” Amendment of section 20

10. Section 20 of the principal Act is amended- (a) in subsection (1), by deleting the closing phrase 9 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 and substituting for it the following: “commits an offence and upon conviction shall be sentenced to a fine of not less than fifty million shillings or to imprisonment for a term of not less than thirty years or to both”; (b) in subsection (2), by deleting the phrase “commits an offence and upon conviction shall be liable” and substituting for it the following: “upon conviction shall be sentenced”; Amendment of section 27 Amendment of section 28

11. The principal Act is amended in section 27 by deleting the phrase “not more than twenty million shillings or to imprisonment for a term of not more than thirty” and substituting for it the phrase “not less than five million shillings but not exceeding fifty million shillings or to imprisonment for a term of not less than five years and not exceeding thirty”.

12. The principal Act is amended in section 28, by: (a) deleting the words “in accordance with” appearing in the seventh line; and (b) deleting the word “Regulations” appearing in the eighth line and substituting for it the words “any other written law”. Amendment of section 29

13. Section 29 of the principal Act is amended- (a) in subsection (1), by: (i) (ii) (iii) in (a) paragraph the words “two hundred” and deleting appearing substituting for them the word “twenty”; deleting appearing substituting for them the word “twenty”; deleting paragraph (c) and substituting for it the following: the words “one hundred” and paragraph (b) in “ (c) 10 that accused person is charged to of an offence relating No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 effect related chemical, other precursor to have substances proved drug or substances used in the process of manufacturing drugs, thirty litres in liquid form and thirty kilograms in solid form or more” ; adding immediately after paragraph (c) the following new paragraph: (iv) “(d) a person is charged under the provisions of sections 16, 20 and

23.” (b) in subsection (2), by deleting the words “Government Chemist” and substituting for it the words “Government Analyst”. Repeal and replacement of section 31

14. The principal Act is amended by repealing section 31 and substituting for it the following: “Release of certain addicts

31.-(1) Where a person is convicted of an offence under section 18 and the court is satisfied that: (a) the person is a drug addict; (b) the addiction resulted or caused or motivated him to commit the offence he is charged with; (c) the addiction be medically treated within a reasonable time; and can (d) it is in the interest of justice nothwithstanding anything contained in this Act or any other written law, the court may record the finding, and that person instead of sentencing immediately to imprisonment, or such other sentence as it could otherwise pass, upon his consent, direct that he be released for detoxification or 11 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 deaddiction to the hospital or an institution maintained or recognized by the Government. (2) The court shall not make any findings under subsection (1) without receiving a written report from a medical expert providing relevant information to the court which shall include: (a) examination of the convicted person; (b) medical assessment regarding the presence and level of any addiction; (c) the nature and availability of any treatment; (d) the likelihood of successful treatment and time scales; and (e) any other information that the medical expert or the court considers relevant. (3) In making a determination under subsection (1), it shall not be in the interests of justice to provide for medical treatment any convicted person in which any of the following aggravating features are present: (a) violence was used or threats; (b) weapon was used; (c) part of a gang or otherwise organized crime; (d) volume of drugs was more than consistent with personal use for an addict; (e) the convicted person had a role in the planning, controlling or facilitating others to commit offences; and (f) any other condition which the court deems fit to consider. (4) The court shall give satisfactory reasons of the basis upon which the findings has been made under subsection (1). (5) When a court makes determination under subsection (1), the court shall postpone the sentence of that person who shall enter into a bond in the form prescribed by the Authority, with or without sureties, for him to undertake the recommended medical treatment. (6) In determining the length of time under subsection (5), the court shall award time not exceeding 12 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 twelve months for completion of the treatment during which period of sentence shall be postponed and the bond extended. (7) The court may, as it deems fit, order a medical report progress be provided in a period not exceeding three month intervals, and such report shall contain assessment of the health condition of the convicted person, levels of cooperation and likely outcome. (8) Before the expiry of twelve months, the convicted person shall appear before the court for consideration of whether or not to be released without further sanction or if the convicted person has failed to cooperate or otherwise has shown bad faith that calls for imposition of sentence for the original offence. Amendment of section 32

15. Section 32 of the principal Act is amended- (a) in subsection (1), by adding at the end of that subsection the following: “and other related offences.” (b) by adding immediately after subsection (1) the following new subsection: the “(2) The officers of the Authority shall, powers under in exercising subsection (1) and where circumstances requires, consult and cooperate with other relevant authorities.”. renumbering subsection (8) as (2) to (c) by subsections (3) to (9); (d) in subsection (7) as renumbered, by deleting the (c) and substituting for it paragraph following: “(c) seize- (i) anything with respect to which any offence has been or is suspected to have been committed; anything with respect to which there are reasonable grounds to suspect that it will afford evidence as to the commission of any offence; or anything in respect of which there are reasonable grounds to suspect that (ii) (iii) 13 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 it is intended to be used for the purpose of committing any offence.” (e) by deleting the renumbered subsection (9). Amendment of section 34

16. The principal Act is amended in section 34, by deleting the phrase “liable to a fine of twenty million shillings or to imprisonment for a term of thirty years or both” and substituting for it the words “sentenced to a fine of not less than five million shillings but not exceeding fifty million shillings or imprisonment for a term of not less than five years but not exceeding thirty years or to both.” Amendment of section 36

17. The principal Act is amended in section 36 - (a) by deleting subsection (1) and substuting for it the following: (b) in subsection 2, by: (i) “(1) The Authority may, having the hazardous nature of any to regard narcotic drugs or psychotropic substances or precursor chemicals or substances used in the process of manufacturing of drugs or other to have drug related substances proved effects, vulnerability to theft, substitution, constraint of proper storage, space or other consideration, dispose of such drugs or substances in accordance with procedures specified under subsections (2) and (3).” inserting the words “or precursor chemicals or substances used in the process of manufacturing of drugs or other substances proved to have drug related effects” between the words “substance” and “shall” appearing in the third line of the opening phrase; adding at the end of paragraph (b), the words “or precursor chemicals or substances used in the process of manufacturing of drugs or other 14 (ii) No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 substances proved related effects; to have drug (c) in subsection (3), by deleting the opening phrase and substituting for it the following: “(3) An officer seizing such narcotic drug, psychotropic substance, precursor chemicals or other substances proved to have drug related effects shall make an application to any magistrate having jurisdiction under this Act, for the purpose of-”; (d) by adding immediately after subsection (3), the following proviso: “Provided that, where is not practicable to secure the presence of the magistrate, the requirement of subsection (3)(b) and (c) shall be dispensed with.”

18. The principal Act is amended in section 38, by it deleting paragraph (c) and substituting for it the following: “(c) machine, equipment, clandestine laboratory, apparatus or any other utensils specially adopted for production or manufacturing of any narcotic drug or psychotropic substance; or”; Amendment of section 38 Addition of section 40A

19. The principal Act is amended by adding immediately after section 40 the following new section: “Right to posses and use firearms and ammunition Cap. 223

40A.-(1) For the purposes of carrying out their functions and duties, the officers of the Authority shall, subject to provisions of Arms and Ammunition Act, or any other written law have the right to possess and use suitable and appropriate firearms and ammunition for the purpose of this Act. Every officer of the (2) Authority shall have powers and privileges as conferred upon other forces by their respective laws relating to the use of firearms and ammunition. the provisions of (3) Any officer charged with 15 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 any duty under this Act may, subject to subsections (4) and (5), use a firearm issued to him against- escaping (a) any person suspected to commit any offence ordered to surrender or is in lawful custody, charged with or convicted of an offence under this Act when such or is person attempting to escape or doing any act posing danger to the officer or property such officer has where reasonable ground to believe that he cannot otherwise prevent the escape and has given a warning to such person that he is about to use such arm against him and such warning is unheeded; (b) any person who by force rescues or attempts to rescue any other person from lawful custody; (c) any person who by force prevents or attempts to prevent the lawful arrest of himself or of any other person where such officer has reasonable ground to believe that he or any other person in danger of grievous bodily harm and that he cannot otherwise effect such arrest or prevent such rescue; is (d) any property placed under custody of the officer or any 16 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 other person is in danger of being destroyed or used as otherwise unlawfully: Provided that, the officer shall not use a firearm unless the use of the firearm and the degree to which it is used is reasonable in the circumstances. (4) The officer under this Act shall not, in the presence of his superior officer, use a firearm against any person except under the orders of that superior officer. (5) The use of a firearm under this section shall, as far as possible, be to disable the suspect, accused or the convicted person, as the case may be. (6) The powers conferred on the officer by this section shall be in addition to and not in derogation of any other powers conferred on such officer by any other witten laws.” Repeal of section 45 Amendment of section 47

20. The principal Act is amended by repealing section 45.

21. The principal Act is amended in section 47, by adding immediately after subsection (2) the following new subsection: “(3) A person who supply information or comply with the requirement of this section commits an offence under this Act.” fails to Amendment of section 48

22. The principal Act is amended in section 48 - (a) by deleting subsection(1) and substituting for it the following: “(1) Subject to the provisions of this Act, the procedures and powers conferred to the officers of the Authority under this Part shall be followed, unless in all circumstances it is unreasonable or impracticable to do so” 17 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 (b) in subsection (2)- (i) in paragraph (a): (aa) by adding the words “unless he submits himself” at the end of subparagraph (i).” (bb) (cc) 18 it by deleting subparagraph (v) and substituting for the following: “(v) cause or require a person arrested to admit or deny the offence in writing within twenty four hours or such other reasonable time and as it may be and extended, where necessary procure a statement before a justice of peace;” by adding immediately after subparagraph the following new subparagraphs: if an officer has audio, (xi) video, digital or other media equipment upon accurate an which recording any interrogation can be made, such officer such use may equipment to make a recording the interrogation of any offence commited under this Act; the Authority may make rules prescribing (xii) (x) of of No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 an (xiv) (xiii) process to be followed by officer conducting interviews subparagraph under (xi); the recording of an in interrogation the accordance with provision of subparagraph (xi) shall be either in addition to or as an alternative to a written caution statement record by the arrested person in accordance with the procedure stated in sub paragraphs (v) to (x); the recording of an interrogation taken in the accordance with of provision subparagraph (xi) shall be admissible as an alternative to a written caution statement; the in record subparagraph (xi) shall be a statement by an officer present the interrogation and such exhibit shall be an admissible evidence of the the record of interrogation; (xvi) a written transcript of all or part of recording in subparagraph (xi) may be made and exhibited by an officer exhibited (xv) in in 19 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 shall who listened to the recording be construed to be true and accurate of the recording.”; (ii) (iii) in paragraph (b), by deleting the word “district” and substituting for it the word “subordinate” appearing in sub paragraph (vii); and in paragraph (c), by: (aa) deleting subparagraph (i) and substituting the following: “(i) for it search stop, and detain any conveyance, to suspected carried have any drug, substances with related drug effects or precursor chemicals substances used in process manufacturing of drug”; the of or (bb) 20 (ii) deleting the phrase “or any substance which has drug related effects” appearing in subparagraph and substituting for it the phrase “any narcotic drug, substance with drug related effects or precursor or substances used in the process of manufacturing of drug.”; chemicals No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 (cc) deleting the phrase “substance with drug related effects” appearing in subparagraph (v) the and substituting for phrase “any narcotic drug, substance with drug related effects or precursor chemicals the or substances used process of manufacturing of drug.”; (c) by adding immediately after subsection (3) the in it Cap. 20 following new sub sections: “(4) Where any objection is taken to the admission of evidence on the ground that the evidence was obtained in contravention with the provisions of this Act or any other written law including the Criminal Procedure Act, the court shall admit the evidence unless having regard to all circumstances including the circumstances in which the evidence was obtained, if it is satisfied that the admission the evidence would have such and of overwhelming adverse effect on the fairness of the proceedings that the court should not admit it. (5) For purposes of carrying out the provision of this section and any other provisions of this Act, all forms set out in the Third Schedule to this Act shall apply.” (d) by renumbering subsection (4 ) as subsection (6). Addition of section 48A

23. The principal Act is amended by adding immediately after section 48 the following new section: “Reports of Government Analysts.

48A.-(1) The Government Analyst to whom a sample of any narcotic drugs, psychotropic substance, precursor chemicals, controlled or any other substances suspected to have drug related effect has been submitted for test and analysis shall deliver to the person submitting it, a signed report in 21 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 quadruplicate in the prescribed form and forward one copy thereof to such authority as may be prescribed. in any force, (2) Notwithstanding anything contained in any other law for the time document being purporting to be a report signed by a Government Analyst be admissible as evidence of the facts stated therein without formal proof and such evidence shall, unless rebutted, be conclusive.” shall Amendment of Part V

24. The principal Act is amended by deleting the heading of Part V and substituting for it the following: “PART V FORFEITURE OF PROPERTY DERIVED FROM OR USED IN COMMISSION OF AN OFFENCE UNDER PART III” Amendment of section 49

25. The principal Act is amended in section 49- (a) by deleting subsection (1) and substituting for it the following: Cap.256 “(1) Where any person is convicted for an offence under Part III, the property owned by him or his associate on the date of charging or acquired by him after that date shall be forteited to the Government in occordance with the Proceeds of Crime Act.”; the provisions of (b) in subsection (3), by deleting paragraph (a) and substituting for it the following: “(a) individual who any is holding property on behalf or managing the affairs of the bussiness of the person convicted”; (c) by deleting subsection (4) and substituting for it the following: (4) A property shall not be forfeited 22 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 under this Part if such property was acquired by a person to whom this Act applies before a period of ten years from the date on which he was charged for an offence under Part III.”; and (d) by deleting subsection (5). Addition of section 49A

26.The principal Act is amendend by adding immediately after section 49 the following new section: “Confiscation of property

49A.-(1) Where the accused is convicted, acquitted or discharged for offences under Part III, the court shall order confiscation of any article seized or property used for purposes of the commiting commission or otherwise involved in the commission of the offence. facilitating the offence or of (2) Where the accused is not the owner of the article or property that is liable for confiscation and owner’s whereabout is not known or cannot be found the confiscation order shall not be issued unless the conditions in subsection (3) are satisfied. (3) An order for confiscation of an article or property shall not be made until- (a) a thirty days notice of intention to confiscate the property has been issued; and (b) the notice has expired without the owner entering appearance. (4) Where the article or property is susceptible to decay, or it appears the sale of such article or property would be necessary for its proper management the court may that article or order 23 the sale of No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Repeal and replacement of section 50 Amendment of section 51 property. (5) A person who claims right to property which has been confiscated under this Act, may make application to the trial court to challenge the confiscation order.”

27. The principal Act is amended by repealing section 50 and replacing for it the following: “Prohibition of holding tainted property

50.-(1) A person shall not hold a property which is tainted either by himself or through any other person on his behalf. (2) Where a person holds a tainted property in contravention of subsection (1), such property shall be the forfeited Proceeds of Crime Act.” in accordance with Cap. 256

28. The principal Act is amended in section 51- (a) in subsection (2), by deleting the words “is charged with any offence whether committed” and substituting for them the words “holds properties whether”; (b) by deleting subsections (5) and (4) and substituting for them the following: “(4) Where it is not practicable to make order for seizure under subsection (3), the officer may make an order that such property shall not be trasferred or otherwise dealt with, subject to the prior permission of the Commissioner General. (c) in subsection 6, by: (5) Where any property referred to in subsection (3) and (4) is transferred by any mode, such transfer shall be void.” (a) inserting the words “in writing” between the words “may” and “call”; and (b) deleting the word “Authority” appearing 24 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 the end of at substituting Government”. for that subsection and the word” it (d) deleting subsection (7) and substituting for it the following: “(7) Where the person affected does not appear or appears and admits that the property he holds was acquired illegaly, the authorised officer may record his findings on the basis of the evidence available before him and submit a report to the Commissioner General.” (e) adding immediately after subsection (7) a new subsection (8) as following: “(8) Where a person referred to under subsection (6) appears before the authorised officer and show cause why all or any of such propeties should not be declared that the illegally acquired, property shall be determined in accordance with the provisions of the Proceeds of Crime Act.” legality of Cap.256 Adition of section 51A

29. The principal Act is amended by adding immediately after section 51 the following new section: “Power of Commisioner General to freeze account under this Act,

51A.-(1) Where a person is under investigation or charged with offences the Commissioner General may where reasonably suspect that any evidence in connection with the offence or property is found in a bank account, freeze that bank account for fourteen days during which leave of the court for continued freezing shall be obtained. (2) Upon application, the court freezing an may extend time for account where there are reasonable ground to suspect that the money held in the is commission of drug offences and other the account related to 25 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 related offences. (3) Where a court extends an account freezing order under subsection (2) it may, at any later time, vary or set aside that order where the continued freezing is no longer required or upon production of additional evidence, the court is satisfied that money held into the account the commission of drug offences and other related offences. is not related to (4) A person who violates or fails to comply with the feezing order commits an offence under this Act.” Repeal of section 52 Repeal and replacement of section 53

30. The principal Act is amended by repealing section

31. The principal Act is amended by repealing section 53 and replacing for it the following: “Declaration of forfeiture of property by Commissioner General

53.-(1) Subject to subsection (4), where the Commissioner General receives a report pursuant to section 51 (7) and he is satisfied that there is resonable ground to believe that the property has been abandoned or illegally acquired he may declare the property the Government. forfeited to be to (2) Where the Commissioner General declares that only a part of a property is subject to forfeiture, he may make an order giving an option to the person affected to pay a sum of money equal to the market value of that part of the property. (3) Where the Commissioner 26 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 General declares the property to be liable for forfeiture under subsection (1), he shall in writing notify the person affected by that declaration within thirty days. (4) A property shall not be forfeited under this section if the property was acquired by a person to whom section 51 applies before a period of ten years prior to the date of commencement of the investigation under section 51. (5) A person aggrieved by the declaration of the Commissioner General may, within thirty days from the date of notification, seek review to the High Court.” Amendment of section 54

32. The principal Act is amended in section 54 by deleting subsection (1) and substituting for it the following: “(1) Where any property is declared forfeited to the Government or the person affected fails to pay the amount of money in lieu of any part of the property declared to be forfeited, the Commissioner General may order the person affected or any other person who may be in possession of that property to surrender or deliver possession of the property.” Amendment of section 55

33. The principal Act is amended in section 55 by deleting subsection (1) and substituting for it the following: “(1) The Government of the United Republic may enter into an arrangement- (a) with the government of a foreign country - (i) (ii) 27 to possession for the recovery and handing over the the United Government of Republic, of any property in that country in respect of which forfeiture has been made; for tracing and preserving any No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 property in that country owned by or under the control of any person who has been convicted of or is suspected to have committed an offence under this Act; or (b) on a reciprocal basis with government of any other country– the (i) (ii) to in over of handing in respect of the recovery of and possession the Government of that country of any property the United Republic which is confiscated by or forfeited to the or Government authority of that country in consequence the commission by any person or his associate of an a against offence corresponding law of that country; or for preserving any property the United Republic in owned by or under the control of any person who has been convicted of, or is suspected to have committed an offence against such corresponding law.” Amendment of section 65

34.The principal Act is amended in section 65, by: (a) deleting the words “Authority may give directions” and substituting for them the words “Commissioner General may give directives”; (b) redesignating the contents of section 65 as subsection (1); 28 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 (c) adding immediately after subsection (1), the following new subsection: “(2) A person who fails to comply with the requirement of this section commits an offence under this Act”. Amendment of the Schedules

35. The principal Act is amended in the Schedules by deleting the First, Second and Third Schedules and substituting for them the following: 29 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 _______ FIRST SCHEDULE ________ (Made under section 14(1)) Schedules of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol, as at 18 May 2016 List of drugs included in Schedule I Acetorphine 3-O-Acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)- 6,14-endo-ethenooripavine Acetyl-alpha-methylfentanyl N-[1-(α-Methylphenethyl)-4-piperidyl]acetanilide Acetylfentanyl N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]acetamide Acetylmethadol 3-Acetoxy-6-dimethylamino-4,4-diphenylheptane AH-7921 3,4-dichloro-N-{[1- (dimethylamino)cyclohexyl]methyl}benzamide Alfentanil N-[1-[2-(4-Ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl) ethyl]-4-(methoxymethyl)-4-piperidinyl]-N- phenylpropanamide Allylprodine 3-Allyl-1-methyl-4-phenyl-4-propionoxypiperidine Alphacetylmethadol α-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane Alphameprodine α-3-Ethyl-1-methyl-4-phenyl-4-propionoxypiperidine Alphamethadol α-6-Dimethylamino-4,4-diphenyl-3-heptanol alpha-methylfentanyl N-[1-(α-Methylphenethyl)-4-piperidyl]propionanilide alpha-methylthiofentanyl N-[1-[1-Methyl-2-(2-thienyl)ethyl]-4-piperidyl] propionanilide Alphaprodine α-l,3-Dimethyl-4-phenyl-4-propionoxypiperidine Anileridine 1-p-Aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester Benzethidine 1-(2-Benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid Benzylmorphine 3-Benzylmorphine ethyl ester Betacetylmethadol β-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane beta-Hydroxyfentanyl N-[1-(β-Hydroxyphenethyl)-4-piperidyl] propionanilide beta-Hydroxy-3-methylfentanyl N-[1-(β-Hydroxyphenethyl)-3-methyl-4-piperidyl] 30 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Betameprodine β-3-Ethyl-1-methyl-4-phenyl-4-propionoxypiperidine propionanilide Betamethadol β-6-Dimethylamino-4,4-diphenyl-3-heptanol Betaprodine β-1,3-Dimethyl-4-phenyl-4-propionoxypiperidine Bezitramide l-(3-Cyano-3,3-diphenylpropyl)-4-(2-oxo-3- propionyl-1-benzimidazolinyl)piperidine Cannabis and cannabis resin and extracts and tinctures of cannabis Clonitazene nitrobenzimidazole Coca leaf 2-(p-Chlorbenzyl)-1-diethylaminoethyl-5- Cocaine Methyl ester of benzoylecgonine Codoxime Dihydrocodeinone-6-carboxymethyloxime Concentrate of poppy straw (the material arising when poppy straw has entered into a process for the concentration of its alkaloids when such material is made available in trade) (“Poppy straw” means all parts (except the seeds) of the opium poppy after mowing) Desomorphine Dihydrodesoxymorphine Dextromoramide (+)-4-[2-Methyl-4-oxo-3,3-diphenyl-4- (1- pyrrolidinyl)butyl]morpholine Diampromide N-[2- (Methylphenethylamino)-propyl]propionanilide Diethylthiambutene 3-Diethylamino-1,1- di-(2’thienyl)-l-butene Difenoxin Dihydroetorphine l-(3-Cyano-3,3- diphenylpropyl)-4-phenylisonipecotic acid 7,8-Dihydro-7α-[1-(R)-hydroxy-1-methylbutyl]-6, 14-endo-ethanotetrahydrooripavine Dihydromorphine Dimenoxadol 2-Dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate Dimepheptanol 6-Dimethylamino-4,4-diphenyl-3-heptanol Dimethylthiambutene 3-Dimethylamino-1,1-di-(2’-thienyl)-1-butene Dioxaphetyl butyrate Ethyl-4-morpholino-2,2-diphenylbutyrate Diphenoxylate 1-(3-Cyano-3,3-diphenylpropyl)-4-phenylpiperidine- 4-carboxylic acid ethyl ester Dipipanone 4,4-Diphenyl-6-piperidine-3-heptanone Drotebanol 3,4- Dimethoxy-17-methylmorphinan-6β,14-diol Ecgonine, its esters and derivatives which are convertible toecgonine and cocaine Ethylmethylthiambutene 3-Ethylmethylamino-1,1-di-(2′-thienyl)-1-butene 31 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Etonitazene 1-Diethylaminoethyl-2-p-ethoxybenzyl-5- nitrobenzimidazole Etorphine Tetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14- endo-ethenooripavine Etoxeridine 1-[2-(2-Hydroxyethoxy)-ethyl]-4-phenylpiperidine- 4-carboxylic acid ethyl ester Fentanyl 1-Phenethyl-4-N-propionylanilinopiperidine Furethidine 1-(2-Tetrahydrofurfuryloxyethyl)-4-phenylpiperidine- 4-carboxylic acid ethyl ester Heroin Diacetylmorphine Hydrocodone Dihydrocodeinone Hydromorphinol 14- Hydroxydihydromorphine Hydromorphone Dihydromorphinone Hydroxypethidine 4-m-Hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester Isomethadone 6-(Dimethylamino)-5-methyl-4,4-diphenyl-3- hexanone Ketobemidone 4-m-Hydroxyphenyl-1-methyl-4-propionylpiperidine Levomethorphana (-)-3-Methoxy-N-methylmorphinan Levomoramide (-)-4-[2-Methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl) butyl]morpholine Levophenacylmorphan (-)-3-Hydroxy-N-phenacylmorphinan Levorphanola (-)-3-Hydroxy-N-methylmorphinan Metazocine 2’-Hydroxy-2,5,9-trimethyl-6,7-benzomorphan Methadone 6-(Dimethylamino)-4,4-diphenyl-3-heptanone Methadone intermediate 4-Cyano-2-dimethylamino-4,4-diphenylbutane Methyldesorphine 6-Methyl-∆6-deoxymorphine Methyldihydromorphine 6-Methyldihydromorphine 3-Methylfentanyl N-(3-Methyl-1-phenethyl-4-piperidyl)propionanilide 3-Methylthiofentanyl N-[3-Methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl] propionanilide Metopon 5-Methyldihydromorphinone 32 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Moramide intermediate 2-Methyl-3-morpholino-1,1-diphenylpropane carboxylic acid Morpheridine 1-(2-Morpholinoethyl)-4-phenylpiperidine-4- carboxylic acid ethyl ester a Dextromethorphan ((+)-3-methoxy-N-methylmorphinan) and dextrorphan ((+)-3-hydroxy-N- methylmorphinan) are specifically excluded from this Schedule. Morphine 33 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Morphine methobromide and other pentavalent nitrogen morphine derivatives Morphine-N-oxide MPPP 1-Methyl-4-phenyl-4-piperidinol propionate (ester) MT- 45 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine Myrophine Myristylbenzylmorphine Nicomorphine 3,6-Dinicotinylmorphine Noracymethadol (±)-α-3-Acetoxy-6-methylamino-4,4-diphenylheptane Norlevorphanol (-)-3-Hydroxymorphinan Normethadone 6-(Dimethylamino)-4,4-diphenyl-3-hexanone Normorphine Demethylmorphine Norpipanone 4,4-Diphenyl-6-piperidino-3-hexanone Opium Oripavine 3-O-Demethylthebaine or 6,7,8,14-tetradehydro-4,5- alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol Oxycodone 14-Hydroxydihydrocodeinone Oxymorphone 14-Hydroxydihydromorphinone para-Fluorofentanyl 4’-Fluoro-N-(1-phenethyl-4-piperidyl)propionanilide PEPAP 1-Phenethyl-4-phenyl-4-piperidinol acetate (ester) Pethidine 1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester Pethidine intermediate A 4-Cyano-1-methyl-4-phenylpiperidine Pethidine intermediate B 4-Phenylpiperidine-4-carboxylic acid ethyl ester Pethidine intermediate C 1-Methyl-4-phenylpiperidine-4-carboxylic acid Phenadoxone 6-Morpholino-4,4-diphenyl-3-heptanone Phenampromide N-(1-Methyl-2-piperidinoethyl)propionanilide Phenazocine 2’-Hydroxy-5,9-dimethyl-2-phenethyl-6,7- benzomorphan Phenomorphan 3-Hydroxy-N-phenethylmorphinan Phenoperidine 1-(3-Hydroxy-3-phenylpropyl)-4-phenylpiperidine- 4-carboxylic acid ethyl ester Piminodine 4-Phenyl-1-(3-phenylaminopropyl)-piperidine-4- carboxylic acid ethyl ester Piritramide 1-(3-Cyano-3,3-diphenylpropyl)-4-(1-piperidino) piperidine-4-carboxylic acid amide Proheptazine 1,3-Dimethyl-4-phenyl-4-propionoxyazacycloheptane 34 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Properidine 1-Methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester Racemethorphan (±)-3-Methoxy-N-methylmorphinan Racemoramide (±)-4-[2-Methyl-4-oxo-3,3-diphenyl-4- (1-pyrrolidinyl)butyl]morpholine Racemorphan (±)-3-Hydroxy-N-methylmorphinan Remifentanil 1-(2-Methoxycarboniylethyl)-4- (phenylpropionylamino)-piperidine-4- carboxylic acid methyl ester Sufentanil N-[4-(Methoxymethyl)-1-[2-(2-thienyl)-ethyl]-4- Thebacon Acetyldihydrocodeinone piperidyl]propionanilide Thebaine Thiofentanyl N-[1-[2-(2-Thienyl)ethyl]-4- piperidyl]propionanilide Tilidine (±)-Ethyl-trans-2-(dimethylamino)-1-phenyl-3- cyclohexene-1-carboxylate Trimeperidine 1,2,5-Trimethyl-4-phenyl-4-propionoxypiperidine The isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation. The esters and ethers, unless appearing in another Schedule, of the drugs in this Schedule whenever the existence of such esters or ethers is possible. The salts of the drugs listed in this Schedule, including the salts of esters, ethers and isomers as provided above whenever the existence of such salts is possible. 35 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 List of drugs included in Schedule II Acetyldihydrocodeine Codeine 3-Methylmorphine Dextropropoxyphene α-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol Dihydrocodeine propionate Ethylmorphine 3-Ethylmorphine Nicocodine 6-Nicotinylcodeine Nicodicodine 6- Nicotinyldihydrocodeine Norcodeine N - Demethylcodeine Pholcodine Morpholinylethylmorphine Propiram N-(1-Methyl-2-piperidinoethyl)-N-2-pyridylpropionamide The isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation. The salts of the drugs listed in this Schedule, including the salts of the isomers as provided above whenever the existence of such salts is possible. List of preparations included in Schedule III

1. Preparations of: Acetyldihydrocodeine Codeine Dihydrocodeine Ethylmorphine Nicocodine Nicodicodine Norcodeine Pholcodine when compounded with one or more other ingredients and containing not more than 100 milligrams of the drug per dosage unit and with a concentration of not more than 2.5 per cent in undivided preparations. 36 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017

2. Preparations of propiram containing not more than 100 milligrams of propiram per dosage unit and compounded with at least the same amount of methylcellulose.

3. Preparations of dextropropoxyphene for oral use containing not more than 135 milligrams of dextropropoxyphene base per dosage unit or with a concentration of not more than 2.5 per cent in undivided preparations, provided that such preparations do not contain any substance controlled under the 1971 Convention on Psychotropic Substances.

4. Preparations of cocaine containing not more than 0.1 per cent of cocaine calculated as cocaine base and preparations of opium or morphine containing not more than 0.2 per cent of morphine calculated as anhydrous morphine base and compounded with one or more other ingredients and in such a way that the drug cannot be recovered by readily applicable means or in a yield which would constitute a risk to public health. Preparations of difenoxin containing, per dosage unit, not more than 0.5 milligram of

5. difenoxin and a quantity of atropine sulfate equivalent to at least 5 per cent of the dose of difenoxin.

6. Preparations of diphenoxylate containing, per dosage unit, not more than

2.5 milligrams of diphenoxylate calculated as base and a quantity of atropine sulfate equivalent to at least 1 per cent of the dose of diphenoxylate. 7 Pulvis ipecacuanhae et opii compositus 10 per cent opium in powder 10 per cent ipecacuanha root, in powder well mixed with 80 per cent of any other powdered ingredient containing no drug. Preparations conforming to any of the formulas listed in this Schedule and mixtures of

8. such preparations with any material which contains no drug. No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 List of drugs included in Schedule IV Acetorphine 3-O-Acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)- 6,14-endo-ethenooripavine Acetyl-alpha-methylfentanyl N-[1-(α-Methylphenethyl)-4-piperidyl]acetanilide Acetylfentanyl N-phenyl-N-[1-(2-phenylethyl)-4- piperidinyl]acetamide alpha-Methylfentanyl N-[1-(α-Methylphenethyl)-4-piperidyl]propionanilide alpha-Methylthiofentanyl N-[1-[1-Methyl-2-(2-thienyl)ethyl]-4-piperidyl] propionanilide beta-Hydroxy-3-methylfentanyl N-[1-(β-Hydroxyphenethyl)-3-methyl-4-piperidyl] propionanilide beta-Hydroxyfentanyl N-[1-(β-Hydroxyphenethyl)-4-piperidyl]propionanilide Cannabis and cannabis resin Desomorphine Dihydrodesoxymorphine Etorphine Tetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14- Heroin Diacetylmorphine endo-ethenooripavine Ketobemidone 4-m-Hydroxyphenyl-1-methyl-4-propionylpiperidine 3-Methylfentanyl N-(3-Methyl-1-phenethyl-4-piperidyl)propionanilide 3-Methylthiofentanyl N-[3-Methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl] propionanilide MPPP 1-Methyl-4-phenyl-4-piperidinol propionate (ester) para- Fluorofentanyl 4’-Fluoro-N-(1-phenethyl-4-piperidyl)propionanilide PEPAP 1-Phenethyl-4-phenyl-4-piperidinol acetate (ester) Thiofentanyl N-[1-[2- (2-Thienyl)ethyl]-4-piperidyl]propionanilide The salts of the drugs listed in this Schedule whenever the formation of such salts is possible. 38 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Schedules on Psychotropic Substances of 1971, as at 13 November 2016of the Convention List of substances in Schedule I International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name 25B-NBOMe, 2C-B-NBOMe 25C-NBOMe, 2C-C-NBOMe 25I-NBOMe, 2C-I-NBOMe 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2- methoxyphenyl)methyl]ethanamine 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2- methoxyphenyl)methyl]ethanamine 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2- methoxyphenyl)methyl]ethanamine Brolamfetamine DOB (±)-4-Bromo-2,5-dimethoxy-α- Cathinone Eticyclidine Etryptamine DET DMA DMHP DMT DOET PCE N-Hydroxy MDA (+)-Lysergide LSD, LSD-25 methylphenethylamine (-)-(S)-2-Aminopropiophenone 3-[2-(Diethylamino)ethyl]indole (±)-2,5-Dimethoxy-α-methylphenethylamine 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro- 6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol 3-[2-(Dimethylamino)ethyl]indole (±)-4-Ethyl-2,5-dimethoxy-α- methylphenethylamine N-Ethyl-1-phenylcyclohexylamine 3-(2-Aminobutyl)indole (±)-N-[α-Methyl-3,4-(methylenedioxy) phenethyl]hydroxylamine 9,10-Didehydro-N,N-diethyl-6- methylergoline-8β-carboxamide MDE, N-Ethyl MDA (±)-N-Ethyl-α-methyl-3,4- (methylenedioxy)phenethylamine MDMA (±)-N,α-Dimethyl-3,4-(methylenedioxy) phenethylamine Mescaline 3,4,5-Trimethoxyphenethylamine Methcathinone 2-(Methylamino)-1-phenylpropan-1-one 4-Methylaminorex (±)-cis-2-Amino-4-methyl-5-phenyl-2- oxazoline MMDA 5-Methoxy-α-methyl-3,4- (methylenedioxy)phenylethylamine No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name 4-MTA α-Methyl-4-methylthiophenethylamine Parahexyl 3-Hexyl-7,8,9,10-tetrahydro-6,6,9- trimethyl-6H-dibenzo[b,d]pyran-1-ol PMA p-Methoxy-α-methylphenylethylamine para- Methoxymethylamphetamine, PMMA 1-(4-methoxyphenyl)-N-methylpropan-2- amine Psilocine, psilotsin 3-[2-(Dimethylamino)ethyl]indol-4-ol Psilocybine 3-[2-(Dimethylamino)ethyl]indol-4-yl hydrogen phosphate Rolicyclidine PHP, PCPY 1-(1-Phenylcyclohexyl)pyrrolidine STP, DOM 2,5-Dimethoxy-α,4- dimethylphenethylamine Tenamfetamine MDA α-Methyl-3,4-(methylenedioxy) phenethylamine Tenocyclidine TCP 1-[1-(2-Thienyl)cyclohexyl]piperidine Tetrahydrocannabinol, the following isomers and their stereochemical variants: 7,8,9,10-Tetrahydro-6,6,9-trimethyl-3- pentyl-6H-dibenzo[b,d]pyran-1-ol 8,9,10,10a-tetrahydro-6,6,9-trimethyl- 3-pentyl-6H-dibenzo[b,d]pyran-1-ol 6a,9,10,10a-Tetrahydro-6,6,9-trimethyl- 3-pentyl-6H-dibenzo[b,d]pyran-1-ol 6a,7,10,10a-Tetrahydro-6,6,9-trimethyl- 3-pentyl-6H-dibenzo[b,d]pyran-1-ol 6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3- pentyl-6H-dibenzo[b,d]pyran-1-ol 6a,7,8,9,10,10a-Hexahydro-6,6- dimethyl-9-methylene-3-pentyl-6H- dibenzo[b,d]pyran-1-ol (±)-3,4,5-Trimethoxy-α- methylphenethylamine TMA The salts of the substances listed in this Schedule whenever the existence of such salts is possible. The stereoisomers, unless specifically excepted, of substances in this Schedule, whenever the existence of such stereoisomers is possible within the specific chemical designation. 40 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 List of substances in Schedule II Other non-proprietary or trivial names Chemical name Int ernational non- proprietary name (INN) α-Pyrrolidinovalero phenone, α-PVP 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one Amfetamine Amphetamine (±)-α-Methylphenethylamine Amineptine 7-[(10,11-Dihydro-5H-dibenzo[a,d] cyclohepten-5-yl)amino]heptanoic acid N-benzylpiperazine, BZP 1-Benzylpiperazine 2C-B 4-Bromo-2,5-dimethoxyphenethylamine Dexamfetamine Dexamphetamine (+)-α-Methylphenethylamine Dronabinol* (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9- trimethyl-3-pentyl-6H-dibenzo[b,d] pyran- 1-ol delta-9- Tetrahydro- cannabinol and its stereochemical variants Fenetylline 7-[2-[(α-Methylphenethyl)amino]ethyl] GHB γ-Hydroxybutyric acid theophylline Levamfetamine Levamphetamine (-)-(R)-α-Methylphenethylamine Levomethamphetamine (-)-N,α-Dimethylphenethylamine Mecloqualone 3-(o-Chlorophenyl)-2-methyl-4(3H) Quinazolinone Mephedrone,4- (RS)-2-(methylamino)-1-(4-methylphenyl) methylmethcathinone propan-1-one Metamfetamine Methamphetamine (+)-(S)-N,α-Dimethylphenethylamine Metafet amine racemte (±)-N,α-Dimethylphenethylamine Methamph etamine racemate Methaqualone 2-Methyl-3-o-tolyl- 4(3H)quinazolinone Methoxetamine, MXE 2-(ethylamino)-2-(3-methoxyphenyl) cyclohexanone 3,4-Methylenedioxypyro- valerone, MDPV Methylone, beta-keto- (RS)-1-(benzo[d][1,3]dioxol-5-yl)-2- (pyrrolidin-1-yl)pentan-1-one (RS)-2-methylamino-1-(3,4- MDMA methylenedioxyphenyl)propan-1-one 41 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Methylphenidate Methyl α-phenyl-2-piperidine acetate JWH-018 Naphthalen-1-yl(1-pentyl-1H-indol-3-yl) methanone AM-2201 1-(5-fluoropentyl)-1H-indol-3-yl]- (naphthalen-1-yl)methanone para-Methyl-4- 4-methyl-5-(4-methylphenyl)-4,5-dihydro- methylaminorex, 4,4’-DMAR Other non- proprietary or trivial names 1,3-oxazol-2-amine Chemical name Internat ional non- proprie tary name (INN) Secobarbital 5-Allyl-5-(1-methylbutyl)barbituric acid Zipeprol α-(α-Methoxybenzyl)-4-(β- methoxyphenethyl)-1- piperazineethanol The salts of the substances listed in this Schedule whenever the existence of such salts is possible. * This INN refers to only one of the stereochemical variants of delta-9- tetrahydrocannabinol, namely (-)-trans-delta-9-tetrahydrocannabinol. List of substances in Schedule III Schedules on Psychotropic Substances of 1971, as at 13 November 2016of the Convention International non- proprietary name (INN) Other non- proprietary or trivial names chemical name Amobarbital 5-Ethyl-5-isopentylbarbituric acid 42 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Buprenorphine 21-Cyclopropyl-7α-[(S)-1-hydroxy- 1,2,2-trimethylpropyl]-6,14-endo- ethano-6,7,8,14-tetrahydrooripavine Butalbital 5-Allyl-5-isobutylbarbituric acid Cathine (+)-Norpseudo-ephedrine (+)-(S)-α-[(S)-1-Aminoethyl]benzyl alcohol Cyclobarbital 5-(l-Cyclohexen-l-yl)-5-ethylbarbituric acid Flunitrazepam 5-(o-Fluorophenyl)-1,3-dihydro-1- methyl- 7-nitro-2H-1,4-benzodiazepin- 2-one Glutethimide 2-Ethyl-2-phenylglutarimide Pentazocine (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro- 6,11-dimethyl-3-(3-methyl-2-butenyl)- 2,6-methano-3-benzazocin-8-ol Pentobarbital 5-Ethyl-5-(1-methylbutyl)barbituric acid The salts of the substances listed in this Schedule whenever the existence of such salts is possible. List of substances in Schedule IV Other non-proprietary or trivial names Chemical name Internat ional non- propriet ary name (INN) Allobarbital 5,5-Diallylbarbituric acid Alprazolam 8-Chloro-1-methyl-6-phenyl-4H-s- triazolo[4,3- a][1,4]benzodiazepine Amfepramone Diethylpropion 2- (Diethylamino)propiophenone Aminorex 2-Amino-5-phenyl-2-oxazoline Barbital 5,5-Diethylbarbituric acid Benzfetamine Benzphetamine N-Benzyl-N-α-dimethylphenethylamine Bromazepam 7-Bromo-1,3-dihydro-5-(2-pyridyl)-2H- 1,4-benzodiazepin-2-one Brotizolam 2-Bromo-4-(o-chlorophenyl)-9-methyl- 6H-thieno[3,2-f]-s-triazolo[4,3- a][1,4]diazepine 43 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Butobarbital 5-Butyl-5-ethylbarbituric acid Camazepam 7-Chloro-1,3-dihydro-3-hydroxy-1- methyl-5-phenyl-2H-1,4-benzodiazepin- 2-one dimethylcarbamate (ester) Chlordiazepoxide 7-Chloro-2-methylamino-5-phenyl-3H- Clobazam 1,4- benzodiazepine-4-oxide 7-Chloro-1-methyl-5-phenyl-1H-1,5- benzodiazepine-2,4(3H,5H)- dione Clonazepam 5-(o-Chlorophenyl)-1,3-dihydro-7- nitro 2H-1,4-benzodiazepin-2-one Clorazepate 7-Chloro-2,3-dihydro-2-oxo-5-phenyl- 1H- 1,4-benzodiazepine-3-carboxylic acid Clotiazepam 5-(o-Chlorophenyl)-7-ethyl-1,3-dihydro- 1-methyl-2H-thieno[2,3-e]-1,4-diazepin- 2-one Cloxazolam 10-Chloro-11b-(o-chlorophenyl)- 2,3,7,11b-tetrahydrooxazolo-[3,2-d] [1,4]benzodiazepin-6(5H)-one Delorazepam 7-Chloro-5-(o-chlorophenyl)-1,3- dihydro- 2H-1,4-benzodiazepin-2-one Diazepam 7-Chloro-1,3-dihydro-1-methyl-

5- phenyl-2H-1,4- benzodiazepin-2-one Estazolam 8-Chloro-6-phenyl-4H-s-triazolo [4,3-a][1,4]benzodiazepine Ethchlorvynol 1-Chloro-3-ethyl-1-penten-4-yn-3-ol Other non-proprietary or trivial names Chemical name Ethinamate 1-Ethynylcyclohexanolcarbamate Ethyl loflazepate Ethyl 7-chloro-5-(o-fluorophenyl)- 2,3- dihydro-2-oxo-1H-1,4- benzodiazepine- 44 Internat ional non- propriet ary name (INN) No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Etilamfetamine N-Ethylamphetamine N-Ethyl-α-methylphenethylamine 3-carboxylate Fencamfamin Fenproporex N-Ethyl-3-phenyl-2-norbornanamine (±)-3-[(α-Methylphenethyl)amino] propionitrile Fludiazepam 7-Chloro-5-(o-fluorophenyl)-1,3-dihydro- 1-methyl-2H-1,4-benzodiazepin-2-one Flurazepam 7-Chloro-1-[2-(diethylamino)ethyl]- Halazepam 5-(o-fluorophenyl)-1,3-dihydro-2H- 1,4-benzodiazepin-2-one 7-Chloro-1,3-dihydro-5-phenyl-1- (2,2,2-trifluoroethyl)-2H- 1,4- benzodiazepin-2-one Haloxazolam 10-Bromo-11b-(o-fluorophenyl)- 2,3,7,11b-tetrahydrooxazolo[3,2- d][1,4]benzodiazepin-6(5H)-one Ketazolam 11-Chloro-8,12b-dihydro-2,8-dimethyl- 12b-phenyl-4H-[1,3]oxazino[3,2-d][1,4] benzodiazepine-4,7(6H)-dione Lefetamine SPA diphenylethylamine (-)-N,N-Dimethyl-1,2- Loprazolam 6-(o-Chlorophenyl)-2,4-dihydro-2- [(4-methyl-1-piperazinyl)methylene]- 8-nitro-1H-imidazo[1,2-a][1,4] benzodiazepin-1-one Lorazepam 7-Chloro-5-(o-chlorophenyl)-1,3- dihydro-3-hydroxy-2H-1,4- benzodiazepin-2-one Lormetazepam 7-Chloro-5-(o-chlorophenyl)- 1,3- dihydro-3-hydroxy-1- methyl-2H- 1,4-benzodiazepin-2-one Mazindol 5-(p-Chlorophenyl)-2,5-dihydro- 3H-imidazo[2,1-a]isoindol-5-ol Medazepam 7-Chloro-2,3-dihydro-1- methyl-5- phenyl-1H-1,4- benzodiazepine Mefenorex N-(3-Chloropropyl)-α- methylphenethyla mine 45 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Meprobamate 2-Methyl-2-propyl-1,3-propanediol dicarbamate International non- proprietary name (INN) Other non-proprietary or trivial names Chemical name Mesocarb 3-(α-Methylphenethyl)-N- (phenylcarbamoyl)sydnone imine Methylphenobarbital 5-Ethyl-1-methyl-5-phenylbarbituric acid Methylprylon 3,3-Diethyl-5-methyl- 2,4- piperidinedione Midazolam 8-Chloro-6-(o-fluorophenyl)-1-methyl- 4H-imidazo[1,5-a][1,4]benzodiazepine Nimetazepam 1,3-Dihydro-1-methyl-7-nitro-5- phenyl-2H-1,4-benzodiazepin-2- one Nitrazepam 1,3-Dihydro-7-nitro-5-phenyl-2H-1,4- benzodiazepin-2-one Nordazepam 7-Chloro-1,3-dihydro-5-phenyl-2H- 1,4-benzodiazepin-2-one Oxazepam 7-Chloro-1,3-dihydro-3-hydroxy-5- phenyl-2H-1,4-benzodiazepin-2- one Oxazolam 10-Chloro-2,3,7,11b-tetrahydro-2- methyl-11b-phenyloxazolo[3,2- d] [1,4]benzodiazepin-6(5H)- one Pemoline 2-Amino-5-phenyl-2-oxazolin-4-one Phendimetrazine (+)-(2S,3S)-3,4-Dimethyl-2- phenylmorpholine Phenobarbital 5-Ethyl-5-phenylbarbituric acid Phenazepam 7-bromo-5-(2-chlorophenyl)-1,3- dihydro- 2H-1,4-benzodiazepin-2-one Phentermine α,α-Dimethylphenethylamine 46 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Pinazepam 7-Chloro-1,3-dihydro-5-phenyl-1-(2- propynyl)-2H-1,4-benzodiazepin-2- one Pipradrol 1,1-Diphenyl-1-(2-piperidyl)methanol Prazepam 7-Chloro-1-(cyclopropylmethyl)- 1,3- dihydro-5-phenyl-2H-1,4- benzodiazepin-2-one Pyrovalerone 4’-Methyl-2-(1-pyrrolidinyl) valerophenone Secbutabarbital 5-sec-Butyl-5-ethylbarbituric acid Temazepam 7-Chloro-1,3-dihydro-3-hydroxy-

1- methyl-5-phenyl-2H-1,4- benzodiazepin-2-one Tetrazepam 7-Chloro-5-(1-cyclohexen-1-yl)- 1,3- dihydro-1-methyl-2H-1,4- benzodiazepin-2-one 47 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Schedules of the Convention on Psychotropic Substances of 1971, as at 13 November 2016 International non-proprietary name (INN) Other non-proprietary or trivial names Chemical name Triazolam 8-Chloro-6-(o-chlorophenyl)-1-methyl 4H-s- triazolo[4,3-a][1,4] Benzodiazepine Vinylbital 5-(1-Methylbutyl)-5-vinylbarbituric acid Zolpidem N,N,6-Trimethyl-2-p-tolylimidazo [1,2-a] pyridine-3-acetamide ________________________ The salts of the substances listed in this Schedule whenever the existence of is possible. such salts 48 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 SECOND SCHEDULE ________ (Made under section 14(2)) Table I Table II Acetone Anthranilic acid Ethyl ether Hydrochloric acid Methyl ethyl ketone Piperidine Sulphuric acid Toluene The salts of the substances listed in this Table whenever the existence of such salts is possible (the salts of hydrochloric acid and specifically acid excluded) sulphuric are Acetic anhydride N-acetylanthranilic acid Ephedrine Ergometrine Ergotamine Isosafrole Lysergic acid 3,4-methylenedioxyphenyl-2-propanon Norephedrine 1-phenyl-2-propanone Alpha-phenylacetoacetonitrile (APAAN) Phenylacetic acid Piperonal Potassium permanganate Pseudoephedrine Safrole The salts of the substances listed in this Table whenever the existence of such salts is possible 49 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 _____ THIRD SCHEDULE _______ (Made under section 48(2)) FORMS THE UNITED REPUBLIC OF TANZANIA THE DRUG CONTROL AND ENFORCEMENT AUTHOIRTY Form No. DCEA 001 FORENSIC LABORATORY SUBMISSION FORM For submission of biological samples/ substances suspected to be drug or precursor chemicals / substances with drug related effects New Submission Resubmission Additional Submission Contact Person Information Submitting Agency: ……………………………………….……………………………… Submitting Officer: Full Name: ……………………….Title……………………………. Physical Address: ………………………………………………………………………… Region ………………………District ………………….Working Station……………… Office Telephone No.: …………………………Mobile Telephone No:…………………. Fax: ……………………...E-mail: …………………………………. Case Information Case No.: …………………………………………………….. Offence: ……………………………………………………… Date of Seizure: ……………………………………………… Area of Seizure: Region ……………………….District ………… Ward………..……… Village/Street:…………………………………… Suspect Information S/n Suspect Name (First, Middle, Last) Sex (F/M) Date of Birth Nationality ID No./ Passport No. 50 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Description of Exhibit Submitted S/No. No of Items and its Description Suspected Drug, chemical or item Request Requested analysis of: (1) Sample identity (2) Drug type (3) Weight of drug (4) Effects of the identified drug to human being Submitted By Full Name of Submitting Officer: ………………………..… Title……………………….. Signature: …………………………………………Date: ………………… Time:……….. Received by Full Name of Receiving Officer: ………………………….. Title: ………………………. Signature: ………………………………………Date: …………………... Time:……….. 51 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 FOMU JAMHURI YA MUUNGANO WA TANZANIA MAMLAKA YA KUDHIBITI NA KUPAMBANA NA DAWA ZA KULEVYA FOMU Na. DCEA 001 FOMU YA UWASILISHAJI SAMPULI MAABARA “Kwa ajili ya uwasilishwaji wa Sampuli za kibaiolojia/vitu vinavyodhaniwa kuwa dawa za kulevya/vitu vyenye madhara yahusianayo na dawa za kulevya sampuli ya nyongeza sampuli mpya Maelezo ya sampuli ya marudio Mwasilishaji Taasisi inayowasilisha Sampuli: ……………………………………………………….…… Majina ya Afisa Mwasilishaji: ……………………….Wadhifa……………………………. Anwani: ……………………………………………………………………………………… Mkoa ……………………… Wilaya………………….Kituo cha kazi ……………………… Simu ya Ofisi: …………………………Simu ya mkononi:…………………………………. Nukushi ……………………...Barua pepe: ……………………………………………………. Taarifa za kesi Namba za Kesi:.: ……………………………………………………….. Kosa: …………………………………………………….…………….. Tarehe ya ukamataji ……………………………………………………. Eneo la ukamataji: ………………………. Mkoa ……………………… Wilaya………………………………………………………………..….. Kijiji/mtaa :………………………………………..……………………… Taarifa za Mtuhumiwa S/N Jina la Mtuhumiwa, (Jina la kwanza, la pili la tatu) Jinsia (ME/KE) Tarehe ya kuzaliwa Uraia Namba ya kitambulisho/pasi ya kusafiria Na. … Maelezo ya kielelezo kinachowasilishwa S/N Idadi ya sampuli/vielelezo na maelezo yanayohusiana nayo/navyo Aina ya kielelezo/sampuli inayodhaniwa kuwa dawa za kulevya, 52 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 kemikali n.k Maombi Maombi ya Uchunguzi: 1) Utambulisho wa Kielelezo/sampuli 2) Aina ya Dawa 3) Uzito wa dawa 4) Madhara kwa binadamu Imewasilishwa na: Jina la Afisa anayewasilisha sampuli: ………………………..… Cheo……………………….. Sahihi: …………………………………………Tarehe: ………………… muda:……….. Imepokelewa na Jina la Afisa Mpokeaji: ………………………….. Cheo: ………………………. Sahihi ………………………………………Tarehe: …………………... muda:……….. 53 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 THE UNITED REPUBLIC OF TANZANIA DRUG CONTROL AND ENFORCEMENT AUTHORITY FORM NO. DCEA 002 CERTIFICATE OF PHOTOGRAPH/MOVING PICTURE ___________ have storage) I, ……………………....……………………………. District/Resident Magistrate, do hereby certify still that ………………………….. pictures/moving pictures stored in ………………………………….. (form of by ………………………. (recording officer) before the disposal of the exhibit namely ……………..…………….this ………………… of ……………………….. 20………… NAME OF THE OFFICER: …………………………….…………… SIGNATURE OF THE OFFICER: ………………………………..… taken/recorded presence in my been day BEFORE ME: NAME:……………………………………………………….. QUALIFICATION: ………………………………………….. ADDRESS:…………………………………………………… SIGNATURE: ………………………………………………. DATE: ……………………………………………………….. 54 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 JAMHURI YA MUUNGANO WA TANZANIA MAMLAKA YA KUDHIBITI NA KUPAMBANA NA DAWA ZA KULEVYA FOMU NA. DCEA002 HATI YA PICHA ZA MNATO/VIDEO ___________ Mimi, ……………………………………………………Hakimu Mkazi/wa Wilaya Nathibitisha kwamba ………………………………………….. picha za mnato/video zilizotunzwa kwenye …………………….. (taja namna ya utunzaji) na ………………………. (Afisa anayepiga picha/video/kabla ya kuteketeza vielelezo/vielelezo (taja) ………. Leo tarehe ……….. mwezi wa ……….. mwaka 20…… zimepigwa/zimechukuliwa mbele yangu JINA LA AFISA: ……………………………………………….... SAHIHI YA AFISA: …………………………………………….. MBELE YANGU: JINA:……………………………………………………………….. SIFA: ………………………………………………………………. ANUANI:…………………………………………………………… SAHIHI: …………………………………………………………….. TAREHE: ……………………………………………………………. 55 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 THE UNITED REPUBLIC OF TANZANIA DRUG CONTROL AND ENFORCEMENT AUTHORITY FORM NO. DCEA 003 CERTIFICATE OF SEIZURE (Made under section 48(2)(c)of DCEA, 2015) ___________ I ………………………...……………..……..(name) …………..……(title) DO HEREBY certify to have conducted a search on …………………..…..…… (date) at .……………………………………… (place) and the under mentioned things/properties were seized:-

10. ………………………………………………………………………………… in the presence of:

1. Name of witness: ………………………….….. of ………………………….. Signature: …………………………………………………………………….

2. Name of Witness: ……………………………………………………………. Signature: .……………………………………………………………………

3. Name(s) of person(s) searched and signature (a) Name: …………………………………………………………………… Signature: …………………………………………………….………….. (b) Name: ……………………………………………………………….…… Signature: ………………………………………………………………… (c) Name: …………………………………………………………………….. Signature: …………………………………………………………………. (d) Name: …………………………………………………………………….. Signature: …………………………………………………………………. (e) Name: ……………………………………………………………………… Signature: …………………………………………………………………. (f) Name: …………………………………………………………………… Signature: …………………………………..…………………………….

4. Name of Executing officer: …………………………………………………… 56 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Signature: ……………………………………………………………………... Date: …………………………………………….……………………………..

5. Name of interpreter (if any) Signature: ……………………………. Date: ………………………………….. 57 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 JAMHURI YA MUUNGANO WA TANZANIA FOMU NA. DCEA 003 MAMLAKA YA KUDHIBITI NA KUPAMBANA NA DAWA ZA KULEVYA HATI YA UKAMATAJI MALI (Chini ya Kifungu cha 48(2)(c)) cha DCEA, 2015) _________ Mimi....................................................................... (jina) ..................................................... (cheo), nathibitisha kuwa nimefanya upekuzi tarehe............................ eneo la ................... (mahali) ambapo vitu vifuatavyo vimekamatwa:

1. .....................................................................................

2. .....................................................................................

3. .....................................................................................

4. .....................................................................................

5. .....................................................................................

6. .....................................................................................

7. .....................................................................................

8. .....................................................................................

9. .....................................................................................

10. ..................................................................................... Mbele ya:

1. Jina la Shahidi:.................................................................. Saini:...........................................................................

2. Jina la Shahidi:................................................................... Saini:........................................................................... ***(MASHAHIDI WATAJAZWA KULINGANA NA MAZINGIRA) Jina/majina na saini za watu waliofanyiwa upekuzi (a) Jina:......................................................... Saini:........................................................ (b) Jina:......................................................... Saini:........................................................ (c) Jina:......................................................... Saini:........................................................ (d) Jina:......................................................... Saini:........................................................ (e) Jina:......................................................... Saini:........................................................ (f) Jina:......................................................... Saini:............................................................................................. Jina la Afisa Mtekelezaji:........................................................................... Saini:............................................................................................................ 58 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Tarehe........................................................................................................... Jina la Mkalimani (kama yupo):................................................................... Sahihi:............................................................................................................ Tarehe:............................................................................................................ 59 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 THE UNITED REPUBLIC OF TANZANIA FORM NO. DCEA 004 DRUG CONTROL AND ENFORCEMENT AUTHORITY OBSERVATION FORM (Made under section 48(2)(c)) of DCEA, 2015) ___________ NAME OF ACCUSED: …………………………………………………………………… UNDER OBSERVATION: ………………………………………………………………... AGE: …………………………………… TRIBE/NATIONALITY ……………………… RESIDENCE: ………………………………. PHONE NUMBER: ……………………… DATE/TIME OF ARREST: ………………………………………………………………. FLIGHT/VESSEL/M/VEHICLE NO: ……………………………………………………. DURING THE OBSERVATION THE ACCUSED EMITTED SOME PELLETS/ SUBSTANCES SUSPECTED TO CONTAIN NARCOTIC DRUGS/SUBSTANCES AS FOLLOWS: TIME DATE PELLETS/ SUBSTANCE EMITTED NAME AND SIGNATURE OF SUSPECT/ ACCUSED NAME AND SIGNATURE OF INDEPENDENT WITNESS NAME AND SIGNATURE OF OFICER Finishing Time: …………………………………………………………………. Declaration of suspects/accused: ………………………………………………… I ……………………………………………do hereby declare that the entries made herein above in respect of the substances emitted are correct according to my knowledge: Dated at ………………………. this ……………….. day of ………………….. 20……. ………………………………………………………….. NAME AND SIGNATURE OF SUSPECT/ACCUSED …………………………………………………………. NAME AND SIGNATURE OF OFFICER OFFICER’S OPINION (if any) …………………………………………..……………….. Name of Officer: ……………………………………………. Signature: ……………………………………………………. Name of witness …………………………………………….. Signature of witness ………………………………………… Name of Interpreter (if any): …………………………………. Signature: ……………………………………………………... 60 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 JAMHURI YA MUUNGANO WA TANZANIA FOMU NA. DCEA 004 MAMLAKA YA KUDHIBITI NA KUPAMBANA NA DAWA ZA KULEVYA FOMU YA UANGALIZI (Chini ya Kifungu cha 48(2)(c)) cha DCEA, 2015) ___________ Jina la mtuhumiwa/mshtakiwa aliye chini ya uangalizi:................................................................... Jinsi: .................................Umri: ............................................................Kabila/Uraia:............................................................ Makazi:.........................................................Simu:............................................................... Kazi...................................................................................................................................... Tarehe na muda wa ukamataji:.............................................................................................. Namba ya Ndege/Meli/Gari/Chombo cha Usafiri:................................................................ Wakati wa uangalizi mtuhumiwa/mshtakiwa ametoa pipi zinazodhaniwa kuwa na dawa za kulevya kama ifuatavyo: Tarehe Muda Idadi ya Pipi zilizotolewa Jina na Saini ya Mtuhumiwa Jina na Saini ya Shahidi Huru Jina na Saini ya Afisa Muda aliomaliza kutoa pipi:................................................................................................. Tamko la Mtuhumiwa/Mshtakiwa aliye Chini ya Uangalizi Mimi.................................................................................. nathibitisha kuwa taarifa iliyoingizwa kwenye jedwali hapo juu kuhusu dawa nilizotoa ni sahihi kwa kadiri ya ufahamu wangu. Imetiwa saini terehe:....................................................................... Jina la Mtuhumiwa/Mshtakiwa:....................................................... Saini ya Mtuhumiwa/Mshtakiwa:...................................................... Jina la Afisa:...................................................................................... Saini ya Afisa:................................................................................... Maoni ya Afisa (kama yapo)............................................................... Jina :.................................................................................................... Saini :......................................................Tarehe.................................. Jina la Mkarimani (kama yupo): ........................................................ Saini: .................................................................................................... 61 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 THE UNITED REPUBLIC OF TANZANIA DRUG CONTROL AND ENFORCEMENT AUTHORITY FORM NO. DCEA 005 CAUTIONED STATEMENT _________________ (Made under Section 48(2) (ix) pf DCEA, 2015) WRITE IN CAPITAL LETTERS NAME OF SUSPECT:…………………………………………………………………… NATIONALITY/TRIBE:…………………........................................................................ AGE: …………………………………………………………………..………………… RELIGION:………………………….…………………………………………………… OCCUPATION:……………………….……………….………………………………… PHYSICAL ADDRESS:………………………STREET/VILLAGE:……………………. WARD:………………………………………………………………………………...… DIVISION:………………………………….DISTRICT:………………………………… REGION:.............................................................................................................................. MOBILE /TEL. NO……………………………………………………………………….. E-MAIL:…………………………………………………………………………………… NAME OF TEN CELL LEADER/WARD SECRETARY...…………………………………………………….……………………… DATE:………………………PLACE:…………………….……………………………… STARTING TIME:……………………………………….………………………………. CAUTIONED STATEMENT ACCORDING TO SECTION 48 OF THE DRUG CONTROL AND ENFORCEMENT ACT (DCEA), No.5 OF 2015 CAUTION: - I …………….............. (Name and Title/Position), warn you............ …………………… ……………………………………………………… that you are accused of an offence of .………………………………………………………… c/s …………………………... You are not obliged to say anything regarding this offence unless you wish to do so. But whatever you say will be recorded and may be used in evidence against you before the court of law once needed. Also you have right to make your statement in presence of a lawyer, relative or friend of your choice to witness it. Recording Officer’s Signature …………Signature of Suspect …………………………… Name of interpreter (if any)...................... Signature........................... Date ........................ RESPONSE:- I………………………………have been warned by …………………………………. that I am of…………………………………………………..c/s ………………. ……………………………… I am not obliged to say anything regarding this offence unless I wish to do so. But whatever I say will be taken down in writing and may be charged with offence the 62 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 used in evidence against me before the court of law once needed. Also I have been given the right to make my statement in presence of a lawyer, relative or friend of my choice to witness it. Signature of Suspect……………Signature of Recording Officer……..………….……… QUESTION:- Are you ready to give out your statement? RESPONSE:- Yes, I am ready/No, I am not ready : (Give reasons): …………………… Signature of Suspect …………………Signature of Recording Officer ….………………. QUESTION: Who would you like to witness your statement? RESPONSE: …………………………………………………………………………………………….. Signature of Suspect………………Signature of Recording Officer ……..…….………… Name of interpreter (if any).............................. Signature ............... Date ........................... the In Date..................................................................... relative/friend/Advocate presence of ................... Signature ...................... STATEMENT:…………………………………………………………………………… ………………………………………………………………………………………………………… ………………………………………………………………………………………………………… ………………………………………………………………………………………………….……… …………………………………………………… CERTIFICATION OF THE SUSPECT under Section I ………………………………………certify that my statement has been correctly recorded without adding or leaving any word. I have read the statement/ The statement was read to me and satisfy myself that it is correct. (To be filled by a suspect. If illiterate, thumb print be used instead) Signature of Suspect: ……………………………………………………………………… CERTIFICATION OF THE RECORDING OFFICER under Section48 (2) (a) (x): I …………………… hereby declare that I have faithfully and accurately recorded the statement of the above named suspect …………………..………………………………… Signature of Recording Officer…………………………………………………………….. FINISHING TIME ………………………………………………………………………. (ix) (2) 48 : 63 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 JAMHURI YA MUUNGANO WA TANZANIA MAMLAKA YA KUDHIBITI NA KUPAMBANA NA DAWA ZA KULEVYA FOMU NA.DCEA 005 KARATASI YA MAELEZO YA ONYO (Chini ya kifungu cha 48(2)(ix)) JALADA LA KESI NA: …………………………….……..…. JINA LA MTUHUMIWA: ……………………………………. KABILA/UTAIFA: …………………………………………… UMRI: ……………………………………………………...….. DINI: ……………………………………………………..…… MAKAZI: ………………………………………..…………..… ANWANI: ………………… MTAA/KIJIJI ………………….. KATA………………………………………………….……….. TARAFA: …………….. SIMU YA MKONONI …………….. SIMU YA OFISINI: ……………… BARUA PEPE: ………… M/KITI WA SERIKALI YA MTAA/KIJIJI…………………………………………………... TAREHE ………………. MAHALI ………………… MUDA WA KUANZA……………………………………………………..... MAELEZO YA ONYO CHINI YA KIFUNGU CHA 48 CHA SHERIA. ya Kifungu ……………. ONYO: Mimi ………………………….. (Jina na Wadhifa) nakuonya wewe …………………. ..……………………………………………………………………… Kwamba unatuhumiwa kwa kosa la …………………………………….. chini sheria ………………………………….. hivyo basi hulazimishwi kusema neno lolote kuhusiana na tuhuma hizi isipokuwa kwa hiari yako mwenyewe, lolote utakalolisema litaandikwa hapa chini na maelezo yako yanaweza kutumika kama ushahidi mahakamani pia unayo haki ya kisheria kuwa na wakili wako, jamaa yako, ndugu yako au rafiki yako ili aweze kushuhudia wakati ukitoa maelezo yako. ………………………. …………………. Saini ya Afisa Mwandishi Saini ya Mtuhumiwa Jina la Mkalimani (kama yupo) …….. sahihi ……… tarehe … cha kwamba Mimi ………………………………………. JIBU LA ONYO la Nimeonywa ………………………………………………chini Kifungu …………….. cha Sheria ……………………….na kwamba silazimishwi kusema neno lolote kuhusiana na tuhuma hizi isipokuwa kwa hiari yangu mwenyewe na kwamba lolote nitakalolisema litaandikwa hapa chini na natuhumiwa kosa kwa ya 64 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 maelezo yangu yanaweza kutumika kama ushahidi mahakamani na kwamba pia ninayo haki ya kisheria kuwa na wakili wangu, jamaa yangu, ndugu au rafiki yangu ili aweze kushuhudia wakati natoa maelezo yangu. ………………………. … ………………… …………. Saini ya Afisa Mwandishi Saini ya mtuhumiwa tarehe SWALI: Je uko tayari kwa sasa kutoa maelezo yako? JIBU: …………………………………………………………... ……………………….…… ……………………… Saini ya Afisa Mwandishi Saini ya mtuhumiwa SWALI: Ungependa nani awepo kushuhudia ukitoa maelezo yako? JIBU: ………………………………………………………….. ………………………. ………………… ……………… Saini ya Afisa Mwandishi Saini ya mtuhumiwa tarehe Jina la Mkalimani (kama yupo)…… Sahihi ………… tarehe … Mbele ya ndugu/Wakili/Rafiki (kama yupo) Jina ………….. sahihi ……………………….. tarehe ………… MAELEZO: …………………………………………………… …………………………………………………………………… …………………………………………………………………… …………………………………………………………………… UTHIBITISHO: Chini ya kifungu cha 48(2)(a)(x) cha sheria Mimi. ………………………………….... nathibitisha kuwa maelezo yangu yameandikwa kwa usahihi bila kuongeza au kupunguza neno. Nimeyasoma na ni sahihi (Aandike mtuhumiwa mwenyewe, kama hajui kusoma na kuandika na aweke dole gumba). Jina la mtuhumiwa ………………. Sahihi …………… UTHIBITISHO: Chini ya kifungu cha 48(2)(a)(x) cha sheria Mimi ……………………………. (jina na wadhifa) nathibitisha kuandika maelezo ya mtuhumiwa ………………….. kwa uaminifu na kama alivyoeleza. Jina la Afisa Mwandishi: ………. …………………… Sahihi: ……………………………………………….. Muda wa kumaliza maelezo: ………………………… 65 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 THE UNITED REPUBLIC OF TANZANIA DRUG CONTROL AND ENFORCEMENT AUTHORITY FORM NO. DCEA 006 INVENTORY OF SEIZED EXHIBIT FOR DISPOSAL (Made under Section 36 (2)) _________________ DAT E INVES TIGATI ON REGIS TER NO. NAME OF DRUG/PRE CURSOR CHEMICA L (Example: Cannabis, Heroin, Khat, cocaine, etc.) DESCRIPT ION OF ARTICLE (Example: mark, form: powder, solid, liquid, crystal, etc.; colour: white, brown, etc.) QUANTI TY (Example: 10 pellets, 20 parcels) ESTIMAT ED WEIGHT/ VOLUME (Example: Kilograms grams, Litres, etc) REMA RKS (Other relevan t inform ation) MODE OF PACKI NG (Exampl e: wrappers , containe r, bag, box, etc.) NAME OF A SUSPECT........................................................................ SIGNATURE OF A SUSPECT:............................................................ (If more than one suspect, add another sheet) NAME OF AN OFFICER:........................................................................ SIGNATURE OF AN OFFICER:............................................................. JUDGE/ MAGISTRATE REMARKS/ORDER:..................................... NAME:.......................................................................................................... QUALIFICATION:..................................................................................... ADDRESS:.................................................................................................... SIGNATURE:............................................................................................... DATE:........................................................................................................... SEAL OF THE OFFICE:............................................................................ 66 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 JAMHURI YA MUUNGANO WA TANZANIA MAMLAKA YA KUDHIBITI NA KUPAMBANA NA DAWA ZA KULEVYA FORM NO. DCEA 006 ORODHA YA VIELELEZO KWA AJILI YA UTEKETEZWAJI (Chini ya kifungu cha 36 (2)) _________________ TARE HE NAMB A ZA USAJI LIW A JALA DA LA UCHU NGUZ I JINA LA DAWA/K EMIKALI BASHIRIF U (Mfano Bangi, Heroin, Cocaine, Mirungi) MAELEZO YA KIELELEZO (Mfano: Alama, umbile, unga, yabisi, kimiminika, chenga chenga n.k. rangi: nyeupe, kahawia n.k) MAKADI RIO YA UZITO/UJ AZO (Mfano: kilo, gramu, lita n.k.) IDADI (Mfano: pili 10, vifurushi 20, gunia 5, debe 10 n.k.) MAEL EKEZ O/MA ONI MENG INE (maele zo mengin e muhim u) AINA YA UFUN GAJI (Mfano : Aina ya kifunga shio, debe, pipa, sanduk u, boksi n.k.) JINA LA MTUHUMIWA............................................................... SAINI YA MTUHUMIWA:............................................................ (Kama ni zaidi ya mmoja ongeza karatasi nyingine) JINA LA AFISA :............................................................................ MAONI/AMRI YA JAJI/HAKIMU:............................................ JINA LA JAJI/HAKIMU:.............................................................. SIFA:................................................................................................. ANWANI:........................................................................................ SAHIHI:........................................................................................... TAREHE:......................................................................................... MUHURI/LAKIRI YA OFISI:...................................................... 67 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 THE UNITED REPUBLIC OF TANZANIA DRUG CONTROL AND ENFORCEMENT AUTHORITY FORM NO. DCEA 007 WITNESS STATEMENT ______________ WRITE IN CAPITAL LETTERS PARTICULARS OF WITNESS NAME OF WITNESS:…………………………………….…………………………… GENDER:.......................................................................................................................... NATIONALITY/TRIBE:…………………...................................................................... AGE:…………………………………………………………………………….………. RELIGION:.……………………………………………………………………………… OCCUPATION:…………………………………………………………….…………… PHYSICAL ADDRESS:……………………STREET/VILLAGE…………………WARD………… ………DIVISION………………DISTRICT…………………………REGION………… MOBILE /TEL. NO……………………………………………………………………….. E-MAIL:…………………………………………………………………………………… NAME OF TEN CELL LEADER/WARD SECRETARY...…………………………………………………….……………………… DATE:………………………………………………PLACE :……………….…………… STARTING TIME:………………………………………………………………………… DECLARATION UNDER SECTION 10 (3) (c) OF CRIMINAL PROCEDURE ACT, CAP 20 [RE 2002] This statement (consisting of . . . . . . . pages each signed by me) is true to the best of my knowledge and belief and I make it knowing that if it is tendered in evidence. I shall be liable to prosecution for perjury if I have willfully stated in it anything, which I know to be false or do not believe to be true. Made at (Place)…………………………..on the …………….day of ………………………. Time …………………………..………………Signature of Witness……………………….. STATEMENT ……………………………………………………………………………………………… ……………………………………………………………………………………………… ……………………………………………………………………………………………… ……………………………………………………………………………………………… ……………………………………………………………………………………………… Signature of Witness……………………….. CERTIFICATION OF THE RECORDING OFFICER under Section 10 (3) of THE CRIMINAL PROCEDURE ACT, CAP 20 [R.E. 2002]. I 68 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 ……………………………………….…hereby declare that I have faithfully and accurately recorded the statement of the above named witness………………………………………………… Signature of Recording Officer………………………. FINISHING TIME …………………………………………….. 69 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 JAMHURI YA MUUNGANO WA TANZANIA MAMLAKA YA KUDHIBITI NA KUPAMBANA NA DAWA ZA KULEVYA FOMU NA. DCEA 007 MAELEZO YA SHAHIDI ______________ JAZA KWA HERUFI KUBWA TAARIFA ZA SHAHIDI JINA:………………………………………………………………………............... JINSI:............................................................................................................................ KABILA/URAIA:…………………............................................................................. UMRI:………………………………………………………...……………………..... DINI:.……………………………………………………….....……………………… KAZI: ………………………………………………………........…………………… ANWANI YA MAKAZI:………………...................................................................… MTAA/KIJIJI………………..................................................................................…… KATA………………………….…..............................................................................… TARAFA………………………………...............................................................……… WILAYA……………………….................................................……………….............. MKOA……………………………… SIMU YA MKONONI/ YA MEZANI:……......................……………………………… BARUA PEPE: …………………………………………..........………………………… JINA LA BALOZI WA NYUMBA KUMI/ KATIBU KATA...………………...............................................................………………………… TAREHE:……………………………MAHALI :………….......................……………… MUDA WA KUANZA KUTOA MAELEZO:………………................………………… 70 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 TAMKO LA SHAHIDI CHINI YA KIFUNGU CHA 10 (3)(c) CHA SHERIA YA MWENENDO WA MAKOSA YA JINAI, [SURA 20, RE 2002] Maelezo haya (yenye kurasa.... zilizosainiwa na mimi) ni ya kweli kwa mujibu wa imani na ufahamu wangu na nayatoa nikijua kuwa endapo yatatolewa mahakamani nitawajibika nayo na naweza kushtakiwa kwa kutoa ushahidi wa uongo endapo nitabainika kuwa maelezo hayo ni ya uongo au kinyume. Maelezo haya yametolewa hapa (mahali)…………………………..leo tarehe ……………. Mwezi ……….............................................................…………Mwaka.......................……. Muda …………………………………………Saini ya Shahidi………......……………….. MAELEZO KAMILI……………………………………………………………..........………………...... ................................................................................................................................................... ................................................................................................................................................... Saini ya Shahidi………………………………………………………………………...…….. UTHIBITISHO: Mimi.............................................................................. (jina na wadhifa) nathibitisha kuwa nimeandika maelezo ya................................................................ (jina la shahidi) kwa uaminifu na usahihi kama alivyoeleza kwa mujibu wa Kifungu cha 10 (3) cha Sheria ya Mwenendo wa Makosa ya Jinai [Sura 20, R.E., 2002]. Saini ya Afisa anayerekodi/anayeandika maelezo:................................................................... Muda wa Kumaliza: ………………………………………………………………...……….. 71 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 THE UNITED REPUBLIC OF TANZANIA DRUG CONTROL AND ENFORCEMENT AUTHORITY FORM NO. DCEA 008 EXTENSION OF TIME TO DETAIN A PERSON(S) OR PROPERTY (IES) (Under Section 48(2)(c)(iii) of DCEA, 2015) _________________ I...................................... (Name and title) on this ...........day of ..............20.... DO HEREBY extend time for a period of ......hours/days to allow further investigation to the under mentioned suspect(s) arrested and/or properties seized. Suspect(s)

5. .................................................................................. .................................................................................. .................................................................................. .................................................................................. .................................................................................. (If more than above suspects, add another sheet) Properties (e.g. motor vehicle, vessel, aircraft, building, etc.):

5. ............................................................................................................................... ............................................................................................................................... ............................................................................................................................... ............................................................................................................................... ............................................................................................................................... (If more than above properties, add another sheet) The suspect (s) has/have been informed accordingly of such extension as witnessed here under.

1. Name(s) of suspect(s): (a) Name: ............................................................................................................ Signature: ............................................................................................................. (b) Name: ............................................................................................................ Signature: ............................................................................................................. (c) Name: ............................................................................................................. Signature: .............................................................................................................. (d) Name: ............................................................................................................. Signature: ............................................................................................................... (e) Name: .............................................................................................................. Signature: ................................................................................................................ 72 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017

2. Officer extending time Name: ...................................................................................................................... Signature: ................................................................................................................ Qualification/Title: .................................................................................................. Date: .........................................................................................................................

3. Interpreter (if any needed) Name: .............................................................................................................. Signature: ......................................................................................................... Date: ................................................................................................................. 73 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 JAMHURI YA MUUNGANO WA TANZANIA MAMLAKA YA KUDHIBITI NA KUPAMBANA NA DAWA ZA KULEVYA FOMU NA. DCEA 008 FOMU YA KUONGEZA MUDA WA KUMWEKA MTUHUMIWA CHINI YA ULINZI AU KUSHIKILIA MALI (Chini ya Kifungu cha 48 (2)(c)(iii) DCEA, 2015) _________________ Mimi............................................................................... (Jina na Cheo) leo hii tarehe ........... Mwezi ..............20.... ninaongeza muda kwa kipindi cha saa/siku ........................... kuruhusu upelelezi zaidi wa mtuhumiwa/watuhumiwa na,au mali zilizoshikiliwa walioorodheshwa/ zilizoorodheshwa hapa chini: Watuhumiwa ................................................................................................................................................... ................................................................................................................................................... ................................................................................................................................................... ................................................................................................................................................... ...................................................................................................................................................

5. (Iwapo kuna watuhumuwa zaidi ya idadi tajwa hapo juu, ongeza karatasi nyingine) Mali (mfano: gari, meli, ndege, jengo, n.k,):

5. ................................................................................................................................................... ................................................................................................................................................... ................................................................................................................................................... ................................................................................................................................................... ................................................................................................................................................... (Iwapo kuna mali zaidi ya idadi tajwa hapo juu, ongeza karatasi nyingine) Mtuhumiwa/watuhumiwa ame/wamejulishwa kuhusu kuongeza muda wa kuwekwa kizuizini na, au kushikiliwa mali kama inavyoshuhudiwa hapa chini: -

6. Jina: .................................................................................................................................................. (a) Saini: ......................................................................................................................................... (b) Jina: ................................................................................................................................... Saini: ......................................................................................................................................... (c) Jina: ................................................................................................................................... Saini: ......................................................................................................................................... 74 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 (d) Jina: ................................................................................................................................... Saini: ......................................................................................................................................... (e) Jina: ................................................................................................................................... Saini: ......................................................................................................................................... Ofisa aliyetoa nyongeza ya muda

2. Jina: ......................................................................................................................................... Saini: ......................................................................................................................................... Cheo: ......................................................................................................................................... Tarehe: ......................................................................................................................................

3. Mkalimani (kama anahitajika) Jina: ......................................................................................................................................... Saini: ......................................................................................................................................... Tarehe: ...................................................................................................................................... 75 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 THE UNITED REPUBLIC OF TANZANIA DRUG CONTROL AND ENFORCEMENT AUTHORITY FORM NO. DCEA 009 THE GOVERNMENT LABORATORY ANALYST REPORT (Under Section 48A(1) of DCEA, 2015) (Name I.................................................................................. the …………………………….(institution), being an officer dully authorised to examine and analyse samples/exhibits, hereby certify as follows: of Chemist) sealed packets/boxes/sacks/containers 1) On the ……… day of …………. 20………. At ……… (place) I received ……… (quantity) applicable) number ………………………. (any marked number) purporting to be sent by …………………….. (institution) suspected to have contained ………………………. (type of exhibit) in the form No. …………… purported to be signed by ……………….. (officer of the institution sending the sample(s)) which were handled to me by ……………………………………… (officer(s) of the institution) and was given Laboratory No………………………..…..….., (whicherver of 2) I have examined and analysed the said samples/exhibits the results of which are stated hereunder: Exhibit “A” …………………………………..……………………(Description of Exhibit) (a) Has been found/not found to have contained drug/substance or substance used in preparation of drug (b) Type of drug/substance or substance used in preparation of drug (if any found) (c) Its weight/volume in kilograms/grams or litres/millilitres (d) Its effect to human health if consumed/applied or used anyhow Exhibit “B” ………………………………………………………(Description of Exhibit) (a) Has been found/not found to have contained drug/substance or substance used in preparation of drug (b) Type of drug/substance or substance used in preparation of drug (if any found) (c) Its weight/volume in kilograms/grams or litres/millilitres (d) Its effect to human health if consumed/applied or used anyhow Other remarks (if any) …………………….……………………………………….. 3) The …………… (quantity) sealed packets/boxes/sacks/containers (whichever applicable) each signed by me, has/have been handled back after examination to …………………… (officer) who brought the sample) Dated at …………… this ………….. day of ………………………………. 20…… Examining officer Name:………………………………………………………………………………….. Signature:……………………………………………………………………………… Title/Qualification:…………………………………………………………………….. Certifying officer: Name:…………………………………………………………..……………………….. Signature:……………………………………………………….……………………….. Title/Qualification:……………………………………………………………….……… Date:……………………………………………………………………........................... 76 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 MAMLAKA YA KUDHIBITI NA KUPAMBANA NA DAWA ZA KULEVYA JAMHURI YA MUUNGANO WA TANZANIA FOMU NA. DCEA 009 TAARIFA YA UCHUNGUZI WA MAABARA YA SERIKALI (Chini ya kifungu 48A(1)) _________________ la (Jina wa ambaye mkemia) la Taasisi), Mimi...................................... Serikali………………………….…….(Jina niliyeidhinishwa kufanya uchunguzi wa vielelezo, nathibitisha kuwa, (1) Tarehe …………../………/20….. eneo la …………………………… (mahali), nilipokea pakiti/sanduku/magunia/kilo ……………………….. (kiasi chochote kinachohusika) yenye namba ……………………… (alama yeyote inayoonekana) kilichowasilishwa kwangu toka ………………………… (taasisi iliyowasilisha kielelezo) kwa kutumia fomu na. ……………….. inayosadikika kusainiwa na ………………… (afisa mwenye dhamana toka taasisi inayowasilisha kielelezo) (2) Nimefanya uchunguzi wa sampuli/kielelezo/vielelezo na kupata matokeo maabara ni ya afisa yafuatayo: Kielelezo “A” (a) Kimegundulika/hakijagundulika kuwa na dawa ya kulevya au kemikali inayoweza kutumika kutengeneza dawa za kulevya (b) Aina ya dawa au kemikali iliyogundulika/zilizogundulika kuwemo (c) Uzito wa dawa/kemikali hizo katika ujazo wa kilogramu/gramu/lita au mililita (d) Athari za dawa/kemikali hiyo endapo itatumiwa na binadamu au kutengeneza dawa za kulevya Kielelezo “B” (a) Kimegundulika/hakijagundulika kuwa na dawa ya kulevya au kemikali inayoweza kutumika kutengeneza dawa za kulevya (b) Aina ya dawa au kemikali iliyogundulika/zilizogundulika kuwemo (c) Uzito wa dawa/kemikali hizo katika ujazo wa kilogramu/gramu/lita au mililita (d) Athari za dawa/kemikali hiyo endapo itatumiwa na binadamu au kutengeneza dawa za kulevya

3. Kiasi Maoni mengine (kama yapo) ……………………………………………………… pakiti/sanduku/magunia/kilo/lita ……………………… (kiasi) zikiwa/yakiwa zimefungwa kwa ikiwa na saini yangu, zimerudishwa baada ya uchunguzi kwa ……………………………… (afisa aliyechukua vielelezo) leo tarehe ….../……/20……… lakiri kila moja cha Aliyefanya uchunguzi: Jina:…………………………… Saini:…………………………. Cheo:………………………….. Afisa anayethibitisha Jina:…………………………….. Saini:……………………………. Cheo:…………………………… Tarehe:………………………….. 77 No. 15 Drug Control and Enforcemement (Amendment) Act, 2017 Passed by the National Assembly on the 17th November, 2017, STEPHEN KAGAIGAI Clerk of the National Assembly 78